The sodium-glutamate antagonist riluzole improves outcome after acute spinal cord injury: results from the RISCIS randomised controlled trial analysed using a global statistical analytic technique.
Fehlings MG, Pedro KM, Alvi MA, Moghaddamjou A, Harrop JS, Stanford R, Ball J, Aarabi B, Arnold PM, Guest JD, Kurpad SN, Schuster JM, Nassr AN, Schmitt KM, Wilson JR, Brodke DS, Ahmad FU, Yee A, Ray WZ, Brooks NP, Wilson J, Chow DS, Toups EG, Thorpe KE, Huang J, Huang P.
Fehlings MG, et al. Among authors: harrop js.
EBioMedicine. 2025 Aug;118:105863. doi: 10.1016/j.ebiom.2025.105863. Epub 2025 Jul 24.
EBioMedicine. 2025.
PMID: 40712181
Free PMC article.
Clinical Trial.